latest news releases from the newsroom
Rosetta Genomics, Ltd.
Rosetta Genomics to Present Advancements in Its Cup Diagnostic Development Program
NEW BRUNSWICK, N.J. and REHOVOT, Israel, April 12, 2007 (PRIME NEWSWIRE) -- Rosetta Genomics, Ltd. (Nasdaq:ROSG), announced today that it will present updated results on its lead diagnostic development program for cancer of unknown primary (CUP), at the upcoming Annual Meeting of the American Association for Cancer Research (AACR), in Los Angeles, California.
ALCO Stores, Inc.
Duckwall-ALCO Stores Reports March Sales Increase of 8.5 Percent
ABILENE, Kan., April 12, 2007 (PRIME NEWSWIRE) -- Duckwall-ALCO Stores, Inc. (Nasdaq:DUCK) today announced that its sales from continuing operations for the five weeks ended April 1, 2007 (fiscal month of March) increased approximately 8.5% to $42.9 million compared to $39.5 million in the prior-year month, and same-store sales increased 7.1% compared to 0.7% in the same period last year.
Clinical Data's Cogenics Division Enters Into Alliance With Epigenomics for DNA Methylation Services
NEWTON, Mass. and BERLIN, Germany, April 12, 2007 (PRIME NEWSWIRE) -- Clinical Data, Inc. (NASDAQ:CLDA) and Epigenomics AG (Other OTC:EPGNF) (FSE:ECX) today announced an agreement to offer Epigenomics' proprietary DNA methylation services through Clinical Data's service division, Cogenics. Under this agreement, Cogenics will promote to its customers Epigenomics' comprehensive portfolio of DNA methylation services including genome-wide DNA methylation analysis, bisulfite sequencing, and real-time PCR technologies, which are performed in Epigenomics' laboratories in Germany. Additionally, the companies plan to offer regulated (GLP) DNA methylation analyses in Cogenics' laboratories in the U.S. Under the agreement, Epigenomics will promote Cogenics' comprehensive pharmacogenomics and molecular biology services to its DNA methylation biomarker development partners and customers that Epigenomics serves through its Clinical Solutions group.